Cost-effective modification of a commercial PCR assay for detection of methicillin-resistant or -susceptible Staphylococcus aureus in positive blood cultures

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1408-1412

  Munson, Erik ^a,b   Kramme, Timothy ^a   Culver, Anne ^a   Hryciuk, Jeanne E ^a   Schell, Ronald F ^c,d  

^a Wheaton Franciscan Laboratory   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REAGENT;

ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM DETECTION; BLOOD CULTURE; CELL LYSATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROCOCCUS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; HUMANS; METHICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 77950485775     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02463-09     Document Type: Article

References (24)

1. Chang, F. Y., J. E. Peacock, Jr., D. M. Musher, P. Triplett, B. D. MacDonald, J. M. Mylotte, A. O'Donnell, M. M. Wagener, and V. L. Yu. 2003. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82:333-339.
2. Cosgrove, S. E., and V. G. Fowler, Jr. 2008. Management of methicillinreslstant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 46(Suppl. 5): S386-S393.
3. Cosgrove, S. E., Y. Qi, K. S. Kaye, S. Harbarth, A. W. Karchmer, and Y. Carmeli. 2005. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol. 26:166-174.
4. Cosgrove, S. E., G. Sakoulas, E. N. Perencevich, M. J. Schwaber, A. W. Karchmer, and Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36:53-59.
5. Desjardins, M., C. Guibord, B. Lalonde, B. Toye, and K. Ramotar. 2006. Evaluation of the IDI-MRSA assay for detection of methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in a selective broth. J. Clin. Microbiol. 44:1219-1223.
6. Diekema, D. J., S. E. Beekmann, K. C. Chapin, K. A. Morel, E. Munson, and G. V. Doern. 2003. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J. Clin. Microbiol. 41:3655-3660.
7. Diekema, D. J., B. J. BootsMiller, T. E. Vaughn, R. F. Woolson, J. W. Yankey, E. J. Ernst, S. D. Flach, M. M. Ward, C. L. Francisais, M. A. Pfaller, and B. N. Dobbeling. 2004. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin. Infect. Dis. 38:78-85.
8. Donnio, P.-Y., F. Février, P. Bifani, M. Dehem, C. Kervégant, N. Wilhelm, A.-L. Gautier-Lerestif, N. Lafforgue, M. Cormier, the MR-MSSA Study Group of the Collège de Bactériologie-Virologie- Hygiène des Hôpitaux de France, and A. Le Coustumier. 2007. Molecular and epidemiological evidence for spread of multiresistant methicillin-susceptible Staphylococcus aureus strains in hospitals. Antimicrob. Agents. Chemother. 51:4342-4350.
9. Gentry, C. A., K. A. Rodvold, R. M. Novak, R. C. Hershow, and O. J. Naderer. 1997. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy 17:990-997.
10. Hensley, D. M., R. Tapia, and Y. Encina. 2009. An evaluation of the AdvanDx Staphylococcus aureus/CNS PNA FISH assay. Clin. Lab. Sci. 22: 30-33.
11. Hoorfar, J., P. Ahrens, and P. Rådström. 2000. Automated 5′ nuclease PCR assay for identification of Salmonella enterica. J. Clin. Microbiol. 38:3429-3435.
12. Huletsky, A., R. Giroux, V. Rossbach, M. Gagnon, M. Vaillancourt, M. Bernier, F. Gagnon, K. Truchon, M. Bastien, F. J. Picard, A. van Belkum, M. Ouellette, P. H. Roy, and M. G. Bergeron. 2004. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J. Clin. Microbiol. 42:1875-1884.
13. Kofler, B., and A. Klausegger. 1999. Simplified PCR set-up using a frozen preformulated mix for the detection of cytomegalovirus. Diagn. Microbiol. Infect. Dis. 34:33-35.
14. Munson, E., T. Block, J. T. Voegeli, J. E. Hryciuk, and R. F. Schell. 2009. Cost-effective frozen master mix modification of a commercial methicillinreslstant Staphylococcus aureus PCR assay. J. Clin. Microbiol. 47:1888-1891.
15. ™ StaphSR assay, abstr. C-116, p. 117. Abstr. 109th Gen. Meet. Am. Soc. Microbiol. American. Society for Microbiology, Washington, DC.
16. Paule, S. M., A. C. Pasquariello, R. B. Thomson, Jr., K. L. Kaul, and L. R. Peterson. 2005. Real-time PCR can rapidly detect methicillin-susceptible and methicillin-reslstant Staphylococcus aureus directly from positive blood culture bottles. Am. J. Clin. Pathol. 124:404-407.
17. Pittet, D., N. Li, R. F. Woolson, and R. P. Wenzel. 1997. Microbiological factors influencing the outcome of nosocomial bloodstream Infections: a 6-year validated, population-based model. Clin. Infect. Dis. 24:1068-1078.
18. Reed, S. D., J. Y. Friedman, J. J. Engemann, R. I. Griffiths, K. J. Anstrom, K. S. Kaye, M. E. Stryjewski, L. A. Szczech, L. B. Reller, G. R. Corey, K. A. Schulman, and V. G. Fowler, Jr. 2005. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 26: 175-183.
19. Small, P. M., and H. F. Chambers. 1990. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:1227-1231.
20. Stamper, P. D., M. Cai, T. Howard, S. Speser, and K. C. Carroll. 2007. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J. Clin. Microbiol. 45:2191-2196.
21. Stone, P., E. Larson, and L. N.- Kawar. 2002. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am. J. Infect. Control 30:145-152.
22. Swenson, J. M., F. C. Tenover, and the Cefoxitin Disk Study Group. 2005. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J. Clin. Microbiol. 43:3818-3823.
23. West, D. M., and J. Sawyer. 2006. Freezing complete polymerase chain reaction master mix reagents for routine molecular diagnostics. J. Vet. Diagn. Investig. 18:580-582.
24. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.